C4 Therapeutics CCCC
NASDAQ CCCC
$3.17 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

C4 Therapeutics (CCCC) Amortization of Deferred Charges (2020 - 2023)

Updated

Analysis

C4 Therapeutics (CCCC) Amortization of Deferred Charges (2020 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 C4 Therapeutics 389.61 Mn -540.14 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 51,000.00
Jun 30, 2023 178,000.00
Mar 31, 2023 176,000.00
Dec 31, 2022 179,000.00
Sep 30, 2022 180,000.00
Jun 30, 2022 178,000.00
Mar 31, 2022 176,000.00
Dec 31, 2021 179,000.00
Sep 30, 2021 180,000.00
Jun 30, 2021 178,000.00
Mar 31, 2021 182,000.00
Dec 31, 2020 180,000.00
Sep 30, 2020 203,000.00
API Access

C4 Therapeutics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=CCCC&period=max&api_key=YOUR_API_KEY